Tumor – see the opportunity

Biestmilch
BiestmiLch
TUMOR
See the opportunity
|
1

In order to understand Biestmilch, you have to set
forth and leave the beaten tracks. The story I would
like to tell you is the one of the orbit in the universe
of biology that Biestmilch is moving along. It is a long
story, one I can only touch on here. It is one thing to
analyse Biestmilch as a substance and break it up into
its individual parts. However, that would be like having
“reckoned without our host”. Rather, approaching
Biestmilch also means occupying yourself with your
own body, with the physiology holding us together
deep inside. You could compare this process with an
expedition.
FOR OUR FOREFATHERS, BIESTMILCH
WAS A FOODSTUFF AND A CURE
Fresh Biestmilch contains everything a newborn child requires.
It contains sufficient fat, bacterial microflora, immunglobulins,
hormones, vitamins, minerals, micronutrients,
mucopolysaccharides and a large number of cell
communication molecules. In the first five to six days after
birth, it is slowly converted into milk and then loses its
unique character. Although it is possible to break down
Biestmilch into its individual parts, we will not, however,
learn its great effects by doing so.
The way Aristotle put it also applies to Biestmilch:
“the whole is greater than the sum of the parts”.
2
Biestmilch
TUMOR – See The OppORTUniTy

TUMOR
See the opportunity
Susann Kraeftner, MD
If you would like to pluck up the courage to make your
own decisions; if you don‘t want to let the opinions of
others make you doubtful, those presented to you in
the outside world and inside clinics and health care
centers, inside the territories of science where one believes
to have entered the realm of truth, if you have
realized for yourself that the only right way is the way
you have chosen for yourself, then give in to reading
the next pages.
OCCUPY YOURSELF WITH BIESTMILCH.
Here, you can find texts I wrote about a natural remedy
that in my opinion cannot be topped when it comes to
the strength and diversity of its effect. And note: Biestmilch
is not harmful to you, doesn‘t hurt you. In order
to understand Biestmilch, you will have to say goodbye
to conventional ways of thinking. There‘s no need to
distance yourself from scientific knowledge but you do
have to move along the borders of science where rethinking
takes place and new things come to life.
A TUMOR IS NOT AN ACCUMULATION
OF MALICIOUS CELLS
You may find that sounds like a provocation. I would
now like to tell you why that is not the case and why
this scientific observation uncovers great opportunities
for you.
Scientists have now also recognized that the opinion
of a tumor comprising an accumulation of malicious
cells, which have withdrawn themselves from growth
control, is not true. This scientific insight is thus to be
discarded and become history.
A NETWORK OF REGULATORY CIRCUITS
CONTROLS THE BALANCE OF THE CELLS
Cancer cells give evidence of defects in the regulatory
circuits which control cell proliferation and the
balance between growth and stagnancy or guide regeneration
and the dying-off of the cells. This process
of maintaining the balance is so varied and can be
disturbed in so many places meaning that today, we
can differentiate between more than 100 types and
subtypes of tumors within one single organ. In other
words, no one type of cancer resembles the other.
How many regulatory circuits in a target cell need to
be broken to stop a tumor from growing and whether
the same or similar regulatory circuits in every tumor
cell are affected in the various tumors remains unknown
to this day. Which regulatory circuits in the cells
run independently from the environment and which
are coupled to signals from the micro-environment
is likewise unexplored. Whether the large number of
cancer-related genes can be tied to certain regulatory
circuits also needs to be researched.
|
3

Tumor cells lose their ability to
communicate.
4
BIESTMILCH
Tumor – see the opportunity

A GENETIC DEFECT ALONE DOES NOT
NECESSARILY LEAD TO A TUMOR DEVELOPING
It can take decades for a tumor to reach a size of medical
significance, i.e. until disorders become evident. Tumors
usually grow very slowly and, in addition to that, a series
of unfortunate circumstances must concur. A defect in the
DNA is not sufficient to make a tumor develop and that is
why a tumor is not simply a collection of malicious cells
whose growth proceeds in an aggressive and uncontrolled
way. And because of this fact, a suitable lifestyle can very
much prevent the development of a tumor.
Thus, for a tumor to start growing, a number of factors
must concur. - There are disorders of the cell biology on
the level of the cell core, the cytoplasm, the receptors, the
extra-cellular matrix and the neighboring cells. The underlying
processes are arranged on a time basis in 3 phases:
1) the initiation of the DNA,
2) the promotion in the intra- and
extra-cellular environment and
3) the progression through tumor-specific
communication processes beyond the primary tumor.
First of all, the cell experiences a genetic change, it is initiated.
It can linger or pause in this state for centuries on
end. This means a tumor never grows. So, as you see, a
genetic defect does not suffice to produce a tumor. However,
if such a cell experiences an irritation such as the influence
of a carcinogen or a chronic inflammatory change
to its environment, then the genetic defect manifests in
the development of a tumor. A chronic inflammatory environment
gives this genetically weak cell a growth advantage
over other cells.
THE TUMOR CELL GROWS INDEPENDENTLY
No cell can multiply itself without the stimulating signals.
In contrast, a tumor cell grows independently; it loses its
coupling to the environment. Many oncogenes function by
copying normal growth signals.
The bridging molecules (connexins) are molecules that are
essential for the communication between cells. Stem cells
are characterized by not carrying such connexins on their
surface. Thus, they have no bridges for communicating
with other cells. These bridging molecules are significantly
involved in controlling the growth of cells and tissues.
Communication is thus an important control process.
A characteristic cancer cell:
1) Self-sufficiency of growth signals
2) Insensitive towards the growth of repressive signals
3) Infiltration of cell termination (apoptosis)
4) Endless potential for proliferation
5) Maintaining the formation of vessels
6) Penetration into the tissue and metastasis
THE CELL‘S ENVIRONMENT IS JUST
AS IMPORTANT AS THE CELL ITSELF
In science, one speaks of epigenetic processes, which play
a central role in the development of tumors.
As you know, the cell comprises one cell nucleus in which
chromosomes, the DNA, the genetic material so to say are
located. Cytoplasm, in which a large number of accumulations
of molecules form structures that are necessary for
the cell to live and to become what it is and what it does,
surrounds this cell nucleus. The cell as a whole is surrounded
by a membrane just like the cell nucleus is. All structures
that form this kind of cell have, on the one hand, Anteile
which have a very flexible shape (receptors, ligands)
and continuously send and receive signals. On the other
hand, they fulfill certain tasks in the cell such as cell respiration
or protein biosynthesis. Thus a stream of signals
flows through the cell, which leads from the cell nucleus to
the environment surrounding the cells and back. In simple
terms, it is a never-ending loop. The resulting changing
signal patterns influence the specific functional state of
the cell. Irrespective of what function a cell has, in principle,
all cells work according to the same principle, and
because they all work in this way, the cells on the various
levels can be influenced in terms of both place and time.
Cell growth is thus not a phenomenon that is controlled
solely by the cell nucleus and its genetic material. The cell
is closely connected to its environment, exchange is narrow
and intensive. Not only do signals/impulses/messages from
the interior of the cell reach the cell‘s surroundings, thus
changing the cell‘s state, but signals/impulses/messages
from the environment likewise inlfuence the cell‘s and the
nucleus cell‘s function and activity. In this way, the cells and
the space between them form an entity of brisk exchange.
|
5

TUMORS DEVELOP IN CHRONIC
inflammatory ENVIRONMENTS
Virchow saw a correlation between inflammation and tumor
back in 1863. Ever since, research has been changing
in such a way that can barely be compared to those times.
And yet, this postulate gained more relevance than ever.
In the meantime we know from some chronic viral infections
that they can make the way for tumors to develop.
And the same applies to chronic inflammations like rheumatism
or chronic inflammatory gastro-intestinal diseases.
Inflammations are usually self-limiting processes. With a
fine-tuned immune response, the immune system makes
sure that inflammatory and anti-inflammatory processes
ultimately lead to healing. Characteristic of the immune
situation of tumor patients is the fact that the immunity
is weakened (suppressed). When a tumor start to grow or
metastasize, then it has usually already infiltrated the immune
system with its monitoring strategies. An intact immune
system patrols the body and removes the cells that
are no longer behaving properly.
Dvorak recognized the similarities between wound healing
and tumors back in 1986. In contrast to a tumor, a wound
heals itself. In a tumor, the process continues by factors
being released unremittingly, which maintain the inflammation.
As is the case with wound healing, the formation
of vessels in the scope of a tumor emerging plays an important
role for a tumor that measures more than one to
two millimeters, blood vessels are vital.
TO PUT IT A NUTSHELL:
In order for a malignant tumor to start growing, an external
or internal trigger, an inflamed environment and damage to
the DNA must concur. An improbable event for an individual?
Many malignant tumors are triggered off by infections. A
history of infection can be assigned to more than 15% of all
tumors worldwide; that is more than 1.2 million cases a year.
Thus, tumors develop as the result of a multi-leveled process,
which leads from an initial benign change to the cells to an
invasive and then metastasizing disease. This process takes
many years until it has fully developed. The long period this
process requires strongly implies that it has to assert itself
against a background of strict and diversified control mechanisms
that are supposed to prevent anarchical cell behavior.
It is thus probable that a certain environment tied to a genetic
disposition changes the cells to such an extent that they
become more receptive for endogenous and exogenous carcinogen
influences. It may depend on whether the carcinogens
can actually trigger off tumor growth and how long it
takes until the process is clinically proven.
IF YOU WANT TO KNOW MORE THEN
YOU MAY BE interested IN WHAT HYPOTHESES
SCIENTISTS ARE CURRENTLY WORKING WITH.
One hypothesis reads as follows: The cell reveals a gene
defect that can no longer be repaired. For this reason, the
external appearance of the cell deviates from that of the
normal cell. Such a cell no longer divides itself up asymmetrically
into a cell with a function (effector cell), which
depends upon which organ or apparatus it is allocated to
and into a stem cell but symmetrically into two cells with
functions. Yet, it is not a tumor cell. As long as the environment
surrounding the cell suppresses cell proliferation, a
tumor does not yet develop.
If, however, a carcinogen or a chronically inflammatory
changed environment affects the cell to the extent that
the brake preventing cell proliferation is released, then the
cell begins to proliferate in an uncontrolled manner. The
result is a mass of cells such as polyps in the colon or papilloma
in the skin. For a so-called malignant tumor to develop,
a number of additional genetic or cellular changes
must occur. It‘s not until now that the step towards the
tumor becoming malignant follows.
Another hypothesis - worded by Potter back in 1978 - explains
the emergence of a tumor as being a blockage of
cell development on their way from the stem cell, where it
still carries a large number of possibilities, to the cell that
is equipped with the function determined for that cell. An
interruption to this development can happen at any stage
of this process. Influences from the cell‘s environment can
speed up cell division and prevent the normal death of the
cell. You have probably often come across the term oncogene.
More than 100 oncogenes have already been identified.
Oncogenes are DNA parts that serve as the template
for the synthesis of protein substances with differing tasks
like growth factors, receptors, signal-transferring molecules.
The tumor suppressor genes have a quasi contrary
task to the oncogenes. They form the template for the
growth of inhibitive factors such as bridging molecules.
These are structural proteins in cell membranes that form
channels for the direct transfer of small molecules and ions
between the cells. The bridging molecules between the
cells are central structures of monitoring growth and differentiating
normal cells. If a gene-defect cell still has bridging
connections, it is still able to develop in its target cell
to a certain extent. Its direct contact to the other cells in
the network inhibits uncontrolled proliferation.
6
BIESTMILCH
Tumor – see the opportunity

|
7

In tumors, the bridging molecules are usually missing.
That means that the cell loses an important component for
its networking with the environment. An activated oncogene
and an inactivated suppressor gene can permanently
stimulate growth.
The objective of the research is to make tumor treatment
that is currently very poor more specific and targeted.
TREATING THE TUMOR PRIMARILY MEANS
INFLUENCING THE CELL‘S ENVIRONMENT
Because no tumor is alike, neither in the same organ nor
past organ boundaries, it can be concluded that targeted
therapeutic approaches are complex and require a casespecific
approach.
Here is an example from experimental research on how
the appearance of the cell and thus its behavior can be
changed by changing the cell‘s environment:
With certain cell growth factors (colony-stimulating factors),
tumor cells can be reprogrammed in such a way
so that they re-integrate into the tissue network with its
control mechanisms, even if they do remain genetically
changed. This result isn‘t actually surprising after what
was said about the significance of the environment for the
emergence of a tumor.
THE BEST TUMOR THERAPY IS PREVENTION
Because most tumors develop slowly over decades, prevention
should stand in first place today. By prevention,
we mean influencing the environment of the genetically
altered cell. Prevention comprises healthy and good quality
food. Eating is the most important environment modulator,
closely followed by regular exercise, i.e. sport, because
physical exercise activates the immune system and
suppresses inflammatory processes that are smoldering in
the body. It is also very important to not eat too much, i.e.
restrict calories.
Biestmilch belongs to the food plan (it is a foodstuff). It is
a kind of immune serum, a substance that is able to calm
down chronic inflammatory tissue.
BIESTMILCH CAN MODULATE
THE INFLAMMATORY ENVIRONMENT
OF THE TUMOR
The inflammatory response should actually contribute
towards removing the tumor cells. However, in the case
of humans with tumors, the inflammatory response is unproductive.
Inflammatory and anti-inflammatory processes
are no longer in balance but have displaced towards the
chronic inflammation. It is typical for the environment of
the tumor for receptors to become insensitive meaning no
effective antitumor response is generated.
Today, the therapeutic challenge principally lies in normalizing
the deregulated inflammatory network in such
a way that the result is a regular inflammatory response.
Thanks to its diversity, Biestmilch as one of the very few
substances available has this potential. Furthermore, it can
stabilize the immune system for chemotherapy to such an
extent that subsequent metastasizing can be influenced.
HOW TO TAKE BIESTMILCH:
You should take Biestmilch every day. Make it part of your
food plan. You don‘t interrupt the intake.
Take 900 mg every day. If you are taking Biestmilch as
preparation for chemotherapy or in addition to that, increase
the amount to 3 x 900 mg every day. After chemotherapy
reduce step by step to 900 mg or 600 mg. In the
case of a repeat chemo-cycle, please increase the dosage
again to 3 x 900 mg.
8
BIESTMILCH
Tumor – see the opportunity

Dr. Susann KrAEftner
„My CV is the contrary of straightforward. I have experienced what
it means to work in intensive care, and psychiatry, in the Civil War of
Lebanon, and in the pharmaceutical industries. For many many years
I was looking for escaping medicine and find a way to get involved
with a more creative way of working. Since 2000 I pursue my life
experiment to resuscitate Colostrum. We call it Biestmilch.“
Find further information and toughts about Biestmilch on
www.biestmilch.com
Sources of literature
Coussens LM, Werb Z: Inflammation and cancer.
Nature, 420: 860 – 867, 2002.
O‘Byrne KJ, Dalgleish AG:
Chronic activation and inflammation
as cause of malignancy.
British Journal of Cancer,
85 (4): 473 – 483, 2001
Shamgar B-E: The promotion of tumor metastasis
by surgery and stress: immunological basis and
implications for psychoneuroimmunology.
Brain, Behaviour and Immunitiy, 17: 27 – 36, 2003
Lotem J, Sachs L: Epigenetics wins over genetics:
induction of differentation in tumor cells.
Cancer Biology, 12: 339 – 346, 2002
Trosko JE: The role of stem cells and gap junctional
intercellular communication in caringenesis.
Journal of Biochemistry and Molecular Biology,
36 (1): 43 – 48, 2003
Trosko JE: Chang CH-Ch, Upham BL, et al.:
Ignored hallmarks of carcinogenesis: stem
cells and cell-cell communication.
Ann. N.Y. Acad. Sci., 1028: 192 – 201, 2004
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell,
100: 57 – 70, 2000
Impressum / IMPrint
Biestmilch Seven GmbH
Herderstraße 31
65185 Wiesbaden, Germany
BIESTMILCH USA, LLC
1129 East Shorewood Court
Coeur d‘Alene, ID 83815
United States
Concept + Text
Dr. Susann Kraeftner
Biestmilch Distribution
TRIXSTERS GmbH
Herderstraße 31
65185 Wiesbaden, Germany
Fon +49 (0)611 - 97651-0
Fax +49 (0)611 - 97651-25
biestmilch@biestmilch.com
www.biestmilch.com/store
Design
designrs frankfurt
www.designrs.de
|
9

Biestmilch
WWW.BieStMiLCh.CoM/Store
BIESTMILCH Chewables
BIESTMILCH Capsules
BIESTMILCH Solution
BIEST BOOSTER MEDIUM*
30 Chewable Tablets
90 Capsules
Flask à 125 ml,
9 Chewable Tablets
à 900mg Colostrum
à 300mg Colostrum
Only available in Europe
à 4000mg Colostrum